BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, MYC, cell-cell adhesion, Leukemia, Hippocampus, Biofuel, Vitamin E)
Bookmark Forward

Antiretroviral drug treatment of CNS HIV-1 infection.

Aylin Yilmaz, Richard W Price, Magnus Gisslén

Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Smörslottsgatan 1, 416 85 Gothenburg, Sweden. aylin.yilmaz@gu.se

The Journal of antimicrobial chemotherapy 2012 Feb


filter terms:
  • anti hiv agents (2)
  • antiretroviral drug (6)
  • drug treatment (1)
  • encephalitis viral (1)
  • hiv 1 (2)
  • hiv infection (2)
  • humans (2)
  • impairment (1)
  • infection (1)
  • patients (2)
  • pharmacokinetics (1)
  • therapy (1)
    • Sizes of these terms reflect their relevance to your search.

    The advent of combination antiretroviral treatment has had a profound impact on CNS HIV infection and its clinical complications, but neurological impairment still occurs in patients on systemically effective combination therapy, and in some patients it may be important to consider antiretroviral drug entry and effects within the CNS. There are now data on the CNS exposure for most antiretroviral drugs. This review focuses on the CNS pharmacokinetics and pharmacodynamics of antiretroviral drugs in humans, and also discusses controversies in this field.

    Citation

    Aylin Yilmaz, Richard W Price, Magnus Gisslén. Antiretroviral drug treatment of CNS HIV-1 infection. The Journal of antimicrobial chemotherapy. 2012 Feb;67(2):299-311

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 22160207

    View Full Text
    • Copyright © 2021 Illumina Inc. All rights reserved.